Why is EMBC down?
Down 55% over three years while the S&P 500 rose 81%.
“The decrease in revenues was primarily driven by $20.1 million of unfavorable changes in price, $19.9 million of unfavorable changes in volume”
Down 55% over three years while the S&P 500 rose 81%.
“The decrease in revenues was primarily driven by $20.1 million of unfavorable changes in price, $19.9 million of unfavorable changes in volume”
EMBC's Quality Score rose 1 point on Tue, Nov 3, to 1. Its 6-month gain rose to 56%, past 30%.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Since its Dec 2022 high | Down 83% |
| Latest filing | 10-Q, Aug 7 |
After its last 4 reports it closed -11.6% on average, higher 1 of 4 times.
Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
EMBC is #59 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 59 |
Expected to report Wed Nov 25, before the open (in 22 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The decrease in revenues was primarily driven by $20.1 million of unfavorable changes in price, $19.9 million of unfavorable changes in volume, and a $0.1 million decrease in contract manufacturing revenue.”
EMBC's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
Sales fell 0.1% a year over 5 years, fiscal 2020 to 2025.
Pays $0.32 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 7, 2026 | +18.3% | +26.3% | +46.0% |
| May 5, 2026 | -45.2% | -57.8% | -63.7% |
| Feb 5, 2026 | +11.1% | -7.8% | -11.4% |
Sales grew in two of the last five years, to $1.1B in 2025. It made a profit in each of the six years.
Its dividends come to 11% of its free cash flow.
| Dividend | $0.32 a share a year |
| Paid out | About $18.1M a year |
| Free cash flow | $165M |
| Record | Cut 93% |
4 insiders bought $558K across 4 filings, and one insider sold $37K across 1 filing, in the last 6 months. The newest:
2 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: EMBC is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
“The diabetes care industry is highly competitive, subject to rapid change and significantly affected by new product introductions and innovation.”
EMBC scores 1 today, which Breakaway calls Below Average. It is #59 of 85 in Medical Devices by Quality Score, with 3 of 14 chart checks firing. Down 55% over three years while the S&P 500 rose 81%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
EMBC scores 1 today, which Breakaway calls Below Average (0 to 5). That is #59 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind EMBC's 1.
4 insiders bought $558K across 4 filings, and one insider sold $37K across 1 filing, in the last 6 months. The newest is Milton Mayo Morris, Director, who sold $37K on Sep 4. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.